NEW YORK (GenomeWeb) – A consortium of researchers has developed a bioinformatic software tool for the annotation and interpretation of pharmacogenetic variants that it hopes will improve the implementation of pharmacogenomics in the clinic.

The software, called Pharmacogenomics Clinical Annotation Tool (PharmCAT), takes PGx variants from sequencing and genotyping data of certain genes, interprets the variant alleles, infers haplotype pairs and star alleles, and generates guideline-based reports that can help physicians make drug prescription decisions.